Disease relevance of Cholangiography

• Stepwise increase in the infusion rate until adequate radiographic visualization is obtained may be the best method for performing intravenous cholangiography to obtain visualization with the least amount of iodipamide in order to minimize toxicity [1].
• Benign recurrent intrahepatic cholestasis: studies of bilirubin kinetics, bile acids, and cholangiography [2].
• Acute cholecystitis at T2-weighted and manganese-enhanced T1-weighted MR cholangiography: preliminary study [3].
• Four patients with primary sclerosing cholangitis (PSC) were examined with the hepatobiliary agent Tc-99m-labeled DISIDA (diisopropylphenylcarbamoyl iminodiacetic acid), and the results correlated with those of invasive cholangiography [4].
• METHODS: MRC and invasive cholangiography (ERCP or PTC) were both performed in 73 patients, (33 male, 40 female, mean age 56 years) with clinical and/or biochemical evidence of cholestasis [5].

High impact information on Cholangiography

• Previous studies have shown that iodipamide (3,3'-(adipoyl-diimino)bis[2,4,6-triiodobenzoic acid]), the radiographic contrast material used for intravenous cholangiography, is a potent choleretic [6].
• Treatment of a solitary hepatic cyst by one-shot instillation of minocycline chloride is reported here; 500 mg of minocycline chloride was instilled into the hepatic cyst, 11 cm in diameter, through a percutaneous transhepatic cholangiography needle under ultrasound guidance [7].
• Twenty patients fulfilled these criteria and were evaluated further for the presence of biliary tract abnormalities with biliary scintigraphy using 99Tc diisopropylphenyl-carboxymethyl iminodiacetic acid (DISIDA) and endoscopic retrograde cholangiography [8].
• Biliary atresia: feasibility of mangafodipir trisodium-enhanced MR cholangiography for evaluation [9].
• The diagnostic specificity and accuracy of contrast-enhanced MR cholangiography were compared with those of conventional MR cholangiography, technetium 99m Tc ((99m)Tc)-disofenin (DISIDA) scintigraphy, and the triangular cord sign at ultrasonography (US) [9].

Chemical compound and disease context of Cholangiography

• Malignant peritoneal mesothelioma after cholangiography with thorotrast [10].
• An abdominal ultrasound, endoscopic retrograde cholangiography, and dimethyl iminodiacetic acid and computed tomographic scans of the abdomen all failed to demonstrate any other causes for jaundice other than amiodarone toxicity [11].
• A case of a choledochal cyst imaged by computed tomography following oral administration of cholangiography contrast material (Telepaque) is reported [12].

Biological context of Cholangiography

• Patients who received Cholografin for intravenous cholangiography, and Renografin 76 for non-cardiac angiography, had low levels of plasma contrast agent, and hemostasis was clinically unimpaired [13].
• One gram of meropenem was administered as prophylaxis to patients undergoing endoscopic retrograde cholangiography (ERC) in a study of the bile pharmacokinetics of this agent [14].
• One-hour infusion intravenous cholangiography with iodipamide was performed in 3 rhesus monkeys with intact enterohepatic circulations [15].

Anatomical context of Cholangiography

• CONCLUSION: The use of the Bismuth classification method appears to be an accurate and practical method for the grading of postoperative bile duct lesions with cholangiography [16].
• PURPOSE: To determine the efficacy of the combined use of magnetic resonance (MR) imaging, MR cholangiography (MRC), and MR angiography (MRA) in the preoperative evaluation of gallbladder carcinoma [17].
• BACKGROUND: Routine intravenous cholangiography using the safer contrast medium, meglumine iotroxate, may be a useful investigation prior to laparoscopic cholecystectomy for the detection of suspected common bile duct stones [18].

Associations of Cholangiography with chemical compounds

• Interpretation of biliary anatomy findings, particularly variants affecting right liver lobe biliary drainage, and degree of interpretation confidence at both 3D mangafodipir trisodium-enhanced MR cholangiography and T2-weighted MR cholangiography were recorded and compared by using the Wilcoxon signed rank test [19].
• CONCLUSION: Helical CT cholangiography may be a clinically useful method for visualization of the biliary tree in some patients with suspected biliary disease with normal bilirubin levels and in patients in whom attempts at ERC fail [20].
• MATERIALS AND METHODS: Eight living potential liver donors underwent iodipamide meglumine-enhanced CT cholangiography [21].
• Cholangiography was performed in these explanted livers, which were then perfused and fixed with formaldehyde [22].
• In all 12 patients, biliary dynamics depicted at manganese-enhanced T1-weighted MR cholangiography agreed completely with those depicted at hepatobiliary scintigraphy [3].

Gene context of Cholangiography

• Tumors in the bile duct were identified by cholangioscopy combined with cholangiography after removal of mucin balls [23].
• Carcinoembryonic antigen in the bile in patients with pancreatic and biliary cancer. Correlation with cytology and percutaneous transhepatic cholangiography [24].
• Percutaneous transhepatic cholangiography (PTC) was performed on a 23-year-old male because of an atypical progression of hepatitis B antigen-negative hepatitis [25].
• Hypotomic cholangiography with glucagon [26].
• To avoid the disadvantages associated with use of the traditional percutaneous transhepatic cholangiography (PTC) needle in ultrasonically guided percutaneous ethanol injection therapy (PEIT) for hepatocellular carcinoma, the authors developed a needle with a three-sided tip and three holes within 3 mm of the tip [27].

Analytical, diagnostic and therapeutic context of Cholangiography

• MATERIALS AND METHODS: Eighteen adult patients with clinically suspected biliary disease who were referred for ERC were first examined with helical CT cholangiography performed 75 minutes after intravenous infusion of 100 mL of 10.3% iodipamide meglumine [20].
• 99mTc HIDA scans, liver ultrasonography, intravenous cholangiography and BSP excretion were of limited value in planning further surgery [28].
• To determine the rational for the ability of glucagon to enhance opacification of the bile ducts during intravenous cholangiography, which has been claimed in recent clinical reports, experiments were performed in dogs which had had Thomas cannulas inserted [29].
• Stent function and biotolerance were assessed by cholangiography, serum bilirubin, and necropsy for histopathology performed in pairs at 2, 4, 6, and 12 months [30].
• METHODS: Flomoxef (1 g) was injected intravenously in eight patients with percutaneous transhepatic cholangiography with drainage at 09.00 h and 21.00 h by a cross-over design with a 36 h washout period [31].

References